Peri-device Leakage Closure After LAAO

CompletedOBSERVATIONAL
Enrollment

85

Participants

Timeline

Start Date

September 27, 2020

Primary Completion Date

September 1, 2021

Study Completion Date

September 1, 2021

Conditions
Atrial FibrillationStrokeBleedingLeakage of Cardiac Device
Interventions
DEVICE

Peri-device leakage closure after left atrial appendage occlusion

Peri-device leakage closure after left atrial appendage occlusion

Trial Locations (16)

2100

Rigshospitalet Copenhagen, Copenhagen

3010

Inselspital Bern, Bern

8200

Aarhus University Hospital, Aarhus

12200

Universitätsmedizin Berlin - Campus Benjamin Franklin (CBF), Berlin

37007

Hospital Universitario de Salamanca, Salamanca

37212

Vanderbilt Heart Institute, Nashville

40225

Universitätsklinikum Düsseldorf, Düsseldorf

55902

Mayo Clinic Hospital - Saint Mary's Campus, Rochester

60389

Cardio Vascular Center Frankfurt, Frankfurt am Main

61701

Poznan University of Medical Sciences, Poznan

66211

Kansas City Heart Rhythm Institute, Overland Park

78756

Austin Heart, Austin

84132

University of Utah Hospital, Salt Lake City

85006

• Banner University Medical Center Phoenix, Phoenix

92037

Scripps Health, La Jolla

OX3 7RP

Nuffield Health, Headington

All Listed Sponsors
lead

Cardiovascular Center Frankfurt

OTHER

NCT04590898 - Peri-device Leakage Closure After LAAO | Biotech Hunter | Biotech Hunter